The Medicinal and Synthetic Chemistry Core (ChemCore) is a shared resource facility dedicated to providing chemistry services for advancing drug discovery and chemical biology research. The facility serves investigators ofthe Robert H. Lurie Comprehensive Cancer Center (RHLCCC), Northwestern University, and external organizations by providing a range of customized services in three primary areas: Cheminformatics, Medicinal and synthetic chemistry, and Compound purification. The cheminformatics service provides computational chemistry, molecular modeling, and computer-aided drug design. These services provide investigators with unique insights into fundamental processes of cancer biology and allow efficient access to powerful platforms to advance early stage drug discovery efforts prior to committing larger resources. The medicinal chemistry service provides researchers with access to high-level resources for the custom synthesis of molecular probe and tools compounds, hit-to-lead chemistry, lead optimization medicinal chemistry, and consulting on drug discovery projects. This service is staffed by professional medicinal chemists who help enable translational research based on the basic research of RHLCCC members. Finally, ChemCore also provides comprehensive instrumentation and expertise to purify and reformat small molecules. Purification services include a full-service custom dual-purpose analytical-to preparative mass-directed HPLC (A2Prep LCMS) and self-service analytical and preparative HPLCs, each equipped with UV and ELS detection. This equipment helps RHLCCC members carry out small molecule chemical biology and drug discovery research much more rapidly. ChemCore works closely with the affiliated RHLCCC High Throughput Analysis Laboratory (HTAL) and Developmental Therapeutics Core (DTC) facilities, which carry out high-throughput screening, in vivo testing, and pre-IND development. Together with these cores, ChemCore provides RHLCCC members and their collaborators with a pipeline to translate basic discoveries into the clinic.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA060553-19
Application #
8588642
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-08-01
Project End
2018-07-31
Budget Start
2013-09-16
Budget End
2014-07-31
Support Year
19
Fiscal Year
2013
Total Cost
$96,447
Indirect Cost
$34,070
Name
Northwestern University at Chicago
Department
Type
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Caralt, M; Uzarski, J S; Iacob, S et al. (2015) Optimization and critical evaluation of decellularization strategies to develop renal extracellular matrix scaffolds as biological templates for organ engineering and transplantation. Am J Transplant 15:64-75
Hung, Andy H; Holbrook, Robert J; Rotz, Matthew W et al. (2014) Graphene oxide enhances cellular delivery of hydrophilic small molecules by co-incubation. ACS Nano 8:10168-77
Gach, Johannes S; Achenbach, Chad J; Chromikova, Veronika et al. (2014) HIV-1 specific antibody titers and neutralization among chronically infected patients on long-term suppressive antiretroviral therapy (ART): a cross-sectional study. PLoS One 9:e85371
Zhao, Baobing; Keerthivasan, Ganesan; Mei, Yang et al. (2014) Targeted shRNA screening identified critical roles of pleckstrin-2 in erythropoiesis. Haematologica 99:1157-67
Keller, Jacob Pearson; Homma, Kazuaki; Duan, Chongwen et al. (2014) Functional regulation of the SLC26-family protein prestin by calcium/calmodulin. J Neurosci 34:1325-32
Daugherty, Rebecca L; Serebryannyy, Leonid; Yemelyanov, Alex et al. (2014) ?-Catenin is an inhibitor of transcription. Proc Natl Acad Sci U S A 111:5260-5
Jensen, Samuel A; Calvert, Andrea E; Volpert, Giora et al. (2014) Bcl2L13 is a ceramide synthase inhibitor in glioblastoma. Proc Natl Acad Sci U S A 111:5682-7
Cull, Elizabeth H; Altman, Jessica K (2014) Contemporary treatment of APL. Curr Hematol Malig Rep 9:193-201
Anderson, Mark T; Dewenter, Lena; Maier, Berenike et al. (2014) Seminal plasma initiates a Neisseria gonorrhoeae transmission state. MBio 5:e01004-13
Gopal, Satish; Achenbach, Chad J; Yanik, Elizabeth L et al. (2014) Moving forward in HIV-associated cancer. J Clin Oncol 32:876-80

Showing the most recent 10 out of 316 publications